1795.TW · LOTUS PHARM
Taiwan · RS rating 17 · As of 2026-10-08
| Price | 180.50 TWD |
|---|---|
| 1-day change | -1.1% |
| RS rating (overall / 1M / 3M / 12M) | 17 / 49 / 24 / 44 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 19 / 23 |
| Industry group (rank) | Biotechnology & Medical Care (50) |
| EPS growth Q/Q | +13.4% |
| Sales growth Q/Q | +1.9% |
| Distance from 52-week high | +50.3% |
| Market cap (USD) | $1.5B |